Skip to main content

Table 1 HSP70-2 expression (RT-PCR/IHC) and clinico-pathologic characteristics of breast cancer

From: Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer

Pathologic and clinical features RT-PCR (%) IHC (%) P value
All tumors 128/154 (83) 128/154 (83) 0.569
 Histotypes
  DCIS 8/8 (100) 8/8 (100)  
  IDC 116/139 (83.4) 116/139 (83.4)  
  ILC 4/5 (80) 4/5 (80)  
  DCIS + IDC 2/2 (100) 2/2 (100)  
 Tumor stages (IDC)
  Stage I 3/3 (100) 3/3 (100)  
  Stage II 68/85 (80) 68/85 (80) 0.388
  Stage III 39/45 (86.7) 39/45 (86.7) 0.343
  Stage IV 6/6 (100) 6/6 (100) 0.341
  Stages
   Early Stages (I + II) 71/88 (80.7) 71/88 (80.7) 0.248
   Late Stages (III + IV) 45/51 (88.2) 45/51 (88.2)  
 Grades
  Grade 1 62/69 (89.8) 62/69 (89.8)  
  Grade 2 39/52 (75) 39/52 (75) 0.029*
  Grade 3 15/18 (83.3) 15/18 (83.3) 0.468
 Lymph node involvement
  Positive 40/51 (78.4) 40/51 (78.4)  
  Negative 76/88 (86.4) 76/88 (86.4)  
  1. *p < 0.017, Bonferroni correction value